Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Bébé is a healthcare company specializing in infant nutrition and pediatric health, primarily focused on the development and distribution of probiotic supplements and organic infant formula. The company is best known for its range of probiotic products containing Lactobacillus reuteri, which are marketed to address common pediatric gastrointestinal issues such as infant colic, diarrhea, and constipation. Bio-Bébé operates as a significant player in the European and Asian markets, often partnering with larger biotechnology firms like BioGaia to distribute clinically validated probiotic strains. Their product portfolio is designed to support the development of a healthy gut microbiome and strengthen the immune system in infants and young children. The company emphasizes organic ingredients and clinical evidence in its formulations to meet the high safety standards required for pediatric healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bio-bebe.